Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma

Publisher： Karger

E-ISSN： 1423-0232|68|4-6|422-431

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 422-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B‐cell lymphoma patients with and without rheumatic disease

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 3, 2015-09 ,pp. : 323-332

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYC protein expression is associated with poor prognosis in primary diffuse large B‐cell lymphoma of the central nervous system

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 7, 2015-07 ,pp. : 596-603

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distinct Gene Expression Profiles: Nodal versus Extranodal Diffuse Large B-Cell Lymphoma

By  

Oncology, Vol. 75, Iss. 1-2, 2008-09 ,pp. : 71-80

Karger

Access to resources Recommend Favorite

Deliverability and efficacy of R‐CHOP chemotherapy in very elderly patients with diffuse large B‐cell lymphoma: an Australian retrospective analysis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1147-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Herpesviridae Viral Infections following Rituximab Combined Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-02 ,pp. : 230-236

Karger

Access to resources Recommend Favorite